id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
ajlm-2132	Gwaza, Gamuchirai P.; Leqheka, Monkoe; Mots’oane, Tsietso; Dittrich, Sabine; Kao, Kekeletso	Missed opportunities for integrated testing of HIV and tuberculosis on the GeneXpert platform in Lesotho	2023		.htm	text/html	5271	263	49	Lesotho’s investment in molecular tuberculosis and HIV testing has progressively increased since this time, and the country has a total of 42 GeneXpert instruments with four modules (GXIV) in 21 health facilities that could be used for tuberculosis and HIV testing and 15 Alere Q instruments in 15 health facilities for HIV POC testing.21 Due to the high tuberculosis and HIV co-infection rates, Lesotho adopted a strategy of using Xpert® MTB/RIF as the primary diagnostic test for presumptive tuberculosis patients to increase the chances of tuberculosis detection.21 The country provided HIV viral load testing for all HIV-positive individuals per the WHO HIV treatment guidelines.20 It also offered HIV EID testing at POC to minimise loss of follow-up. On average, there were four trained staff for tuberculosis testing and three for HIV testing on the GeneXpert instrument.	cache/ajlm-2132.htm	txt/ajlm-2132.txt